Morgan Stanley’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $35.3M | Sell |
|
|||||
|
2022
Q2 | $22.5M | Buy |
|
|||||
|
2022
Q1 | $10.6M | Buy |
|
|||||
|
2021
Q4 | $14.1M | Buy |
|
|||||
|
2021
Q3 | $2.84M | Sell |
|
|||||
|
2021
Q2 | $5.2M | Buy |
|
|||||
|
2021
Q1 | $18.1M | Buy |
|
|||||
|
2020
Q4 | $3.6M | Buy |
|
|||||
|
2020
Q3 | $1.72M | Sell |
|
|||||
|
2020
Q2 | $5.74M | Buy |
|
|||||
|
2020
Q1 | $1.33M | Sell |
|
|||||
|
2019
Q4 | $3.63M | Sell |
|
|||||
|
2019
Q3 | $1.02M | Buy |
|
|||||
|
2019
Q2 | $52K | Sell |
|
|||||
|
2019
Q1 | $254K | Sell |
|
|||||
|
2018
Q4 | $432K | Sell |
|
|||||
|
2018
Q3 | $615K | Sell |
|
|||||
|
2018
Q2 | $723K | Sell |
|
|||||
|
2018
Q1 | $1.27M | Sell |
|
|||||
|
2017
Q4 | $894K | Buy |
|
|||||
|
2017
Q3 | $681K | Sell |
|
|||||
|
2017
Q2 | $1.09M | Sell |
|
|||||
|
2017
Q1 | $896K | Buy |
|
|||||
|
2016
Q4 | $820K | Buy |
|
|||||
|
2016
Q3 | $95K | Sell |
|
|||||
|
2016
Q2 | $248K | Buy |
|
|||||
|
2016
Q1 | $22K | Sell |
|
|||||
|
2015
Q4 | $118K | Buy |
|
|||||
|
2015
Q3 | $78K | Sell |
|
|||||
|
2015
Q2 | $344K | Buy |
|
|||||
|
2015
Q1 | $196K | Buy |
|
|||||
|
2014
Q4 | $44K | Hold |
|
|||||
|
2014
Q3 | $29K | Sell |
|
|||||
|
2014
Q2 | $120K | Buy |
|
|||||
|
2014
Q1 | $128K | Sell |
|
|||||
|
2013
Q4 | $380K | Sell |
|
|||||
|
2013
Q3 | $816K | Buy |
|
|||||
|
2013
Q2 | $306K | Buy |
|